Oncolytics Biotech Inc
Officers & Directors
The named executive officers in 2025 were Jared Kelly, Chief Executive Officer (appointed in June 2025); Wayne Pisano, former Interim CEO; Kirk Look, Chief Financial Officer; and Thomas C. Heineman, Chief Medical Officer. Jared Kelly's 2025 annual base salary was established during his hiring negotiations. Wayne Pisano served as Interim CEO with a monthly salary of CAD$14,600 in 2024 and $20,000 in 2025. Kirk Look and Thomas C. Heineman's base salaries remained unchanged from 2024. Short-term incentive bonuses were available to all named executives, with eligibility percentages of base salary as follows: Kelly up to 50% (pro-rated), Pisano 50%, Look 40%, and Heineman 40%. Bonuses were based on corporate objectives related to clinical development and financing to strengthen capital and shareholder value. The Compensation Committee awarded a corporate achievement level of 50% for 2025, which was used to determine bonuses.
Oncolytics Biotech Inc currently has 29 employees.
|
